Since March 2004, CombiMatrix has been awarded a $5.9 million contract, a $2.1 million contract that is currently in process, and the latest allocation of $2.4 million for its detection technologies.
Under previously funded programs with US government agencies, CombiMatrix has multiplexed its microarray for the simultaneous detection of toxins, viruses, and bacteria using immunoassay and genomic analysis.
Unique to the platform is ‘on chip’ electrochemical detection, which eliminates the need for a large, complex and expensive optical system.
“This funding will allow us to continue our efforts to create a reliable and cost-effective system for identifying both chemical and biological threat agents,” stated Dr David Danley, director of homeland security and defense programs at CombiMatrix. “We anticipate that our success to date and future success on this program will enable us to continue working with the US government to meet its military, defense and anti-terrorist needs.”